Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen H Nagami

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Open Forum Infectious Diseases|February 3, 2022
Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass ResistanceEllen H Nagami, Kinna Thakarar, Paul E Sax
Topics in Antiviral Medicine|November 17, 2012
Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patientEllen H Nagami, Arthur Y Kim, Rachel P Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2010
A "one-two punch" leading to hepatitis C seroconversionEllen H Nagami, Arthur Y Kim, Christopher E Birch, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug usersArthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With TafenoquineRalph Rogers, Peter J Krause, Ashlyn M Norris, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
Annals of Internal Medicine|June 30, 2015
Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart reviewShauna Onofrey, Jasneet Aneja, Gillian A Haney, et al.
Open Forum Infectious Diseases|August 11, 2022
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United StatesWilfredo R Matias, Jacob M Koshy, Ellen H Nagami, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Open Forum Infectious Diseases|February 3, 2022
Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass ResistanceEllen H Nagami, Kinna Thakarar, Paul E Sax
Topics in Antiviral Medicine|November 17, 2012
Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patientEllen H Nagami, Arthur Y Kim, Rachel P Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2010
A "one-two punch" leading to hepatitis C seroconversionEllen H Nagami, Arthur Y Kim, Christopher E Birch, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug usersArthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With TafenoquineRalph Rogers, Peter J Krause, Ashlyn M Norris, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
Annals of Internal Medicine|June 30, 2015
Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart reviewShauna Onofrey, Jasneet Aneja, Gillian A Haney, et al.
Open Forum Infectious Diseases|August 11, 2022
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United StatesWilfredo R Matias, Jacob M Koshy, Ellen H Nagami, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 1